{"id":"W2123407823","doi":"10.1016/j.healthpol.2009.12.001","title":"The US Orphan Drug Act: Rare disease research stimulator or commercial opportunity?","year":2009,"lang":"en","type":"article","venue":"Health Policy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":167,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Orphan drug; Medicine; Rare disease; Drug approval; Drug; Business; Disease; Pharmacology; Bioinformatics; Biology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01573376,0.0005953143,0.001560373,0.001675461,0.001780014,0.005274024,0.001378281,0.01658704,0.01556044],"category_scores_gemma":[0.06793872,0.0004434959,0.001052227,0.002417066,0.004845775,0.005588746,0.002598877,0.00970965,0.003203678],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003452713,"about_ca_system_score_gemma":0.01667241,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01693051,"about_ca_topic_score_gemma":0.02480668,"domain_scores_codex":[0.9884806,0.004996538,0.001208226,0.0007152642,0.00328134,0.001318079],"domain_scores_gemma":[0.9403089,0.03981241,0.006118554,0.002430269,0.005612693,0.005717251],"domain_codex":null,"domain_gemma":"incentives","domain_candidate":"incentives","domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.0003517942,0.0001390852,0.005087509,0.0003757185,0.00008915021,0.0003503351,0.0002508316,0.0003664079,0.0002976748,0.3492343,0.5798295,0.0636277],"study_design_scores_gemma":[0.0002242417,0.0001377709,0.009890253,0.002126788,0.0001340264,0.0005544655,0.0003728434,0.0009396133,0.0003313638,0.07711156,0.9080868,0.00009018692],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.004861875,0.01334401,0.001248742,0.8976984,0.01413118,0.00005676558,0.001639991,0.0001533966,0.0668657],"genre_scores_gemma":[0.1298515,0.02027599,0.006206586,0.7593598,0.02329984,0.0006305428,0.001330957,0.0001366767,0.05890807],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.9842662,"threshold_uncertainty_score":0.0832091,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.6418563350695778,"score_gpt":0.5849221294692968,"score_spread":0.05693420560028106,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}